NLRP14 Antikörper (AA 81-180) (AbBy Fluor® 555)
-
- Target Alle NLRP14 Antikörper anzeigen
- NLRP14 (NLR Family, Pyrin Domain Containing 14 (NLRP14))
-
Bindungsspezifität
- AA 81-180
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser NLRP14 Antikörper ist konjugiert mit AbBy Fluor® 555
-
Applikation
- Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
- Kreuzreaktivität
- Human
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human NLRP14
- Isotyp
- IgG
- Top Product
- Discover our top product NLRP14 Primärantikörper
-
-
- Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- NLRP14 (NLR Family, Pyrin Domain Containing 14 (NLRP14))
- Andere Bezeichnung
- NLRP14 (NLRP14 Produkte)
- Synonyme
- 4921520L01Rik antikoerper, GC-LRR antikoerper, Nalp-iota antikoerper, Nalp14 antikoerper, Nalp14l antikoerper, NALP14 antikoerper, CLR11.2 antikoerper, NOD5 antikoerper, PAN8 antikoerper, NLR family, pyrin domain containing 14 antikoerper, NLR family pyrin domain containing 14 antikoerper, Nlrp14 antikoerper, NLRP14 antikoerper
- Hintergrund
-
Synonyms: NACHT, LRR and PYD domains-containing protein 14, NLRP14, Nucleotide-binding oligomerization domain protein 5, NOD5
Background: May be involved in inflammation and spermatogenesis.
- Gen-ID
- 338323
- UniProt
- Q86W24
- Pathways
- Inflammasome
-